MANHATTAN SCIENTIFICS INC (MHTX) [Rocket]

Overview

MANHATTAN SCIENTIFICS INC (MHTX)

Add to portfolio

1m \| 3m \| 6m \| 1y \| 2y \| 5y \| 10y

Recent News + Filings (All items)

Date Filed	Type	Description
08/21/2023	10-Q	Quarterly Report for the period ended June 30, 2023
08/14/2023	NT 10-Q	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
05/31/2023	10-Q/A	Quarterly Report for the period ended March 31, 2023 [amend]
05/15/2023	NT 10-Q	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
04/13/2023	10-K	Annual Report for the period ended December 31, 2022
03/31/2023	NT 10-K	Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
11/14/2022	10-Q	Quarterly Report for the period ended September 30, 2022

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15	Dec-31-14	Dec-31-13
Revenues	0.1	0.1	0.0	0.1	0.2	0.1	0.6	0.7
Revenue growth	-48.5%		-100.0%	-5.3%	134.4%	-90.0%	-1.5%	-5.9%
Cost of goods sold	0.0	0.0	0.0	0.2	0.0	-21.3	0.0	-3.4
Gross profit	0.1	0.1	0.0	0.0	0.1	21.3	0.6	4.1
Gross margin	100.0%	100.0%		-33.1%	71.3%	33307.8%	100.2%	624.5%
Research and development	0.0	0.0	0.1	0.2	3.3	2.9	1.9	1.0
General and administrative	0.7	1.1	1.4	2.1	3.2	3.4	2.3	1.5
EBITA	-0.7	-1.0	-4.2	5.7	-6.4	8.7	-3.5	-0.6
EBITA margin	-1350.0%	-1056.7%		3987.3%	-4255.3%	13573.4%	-541.1%	-95.2%
Amortization of intangibles								0.2
EBIT	-0.7	-1.0	-4.2	5.7	-6.4	8.7	-3.5	-0.8
EBIT margin	-1350.0%	-1056.7%		3987.3%	-4255.3%	13573.4%	-541.1%	-130.1%
Pre-tax income	4.3	-1.2	-8.3	1.5	-6.1	8.0	-3.8	-1.9
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	4.3	-1.2	-8.3	1.5	-6.1	8.0	-3.8	-1.9
Net margin	8628.0%	-1259.8%		1088.7%	-4072.0%	12518.8%	-592.7%	-295.7%

Diluted EPS	$0.01	$0.00	($0.02)	$0.00	($0.01)	$0.01	($0.01)	$0.00
Shares outstanding (diluted)	593.1	549.4	533.8	533.8	534.7	593.4	485.6	461.1

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.